Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The Journal of the Association of Physicians of India
|
July 3, 2020
Study of Beneficial Impact on Specific Biomarkers in Type 2 Diabetes During Ramadan Fasting (Unintentional Intermittent Fasting)
Rajiv Kovil, Nida Shaikh
Indian Journal of Endocrinology and Metabolism
|
January 10, 2014
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Mumbai cohort of the A1chieve study
P G Talwalkar, Vishal Gupta, Rajiv Kovil
The Journal of the Association of Physicians of India
|
September 26, 2020
Single-pill Combination of Empagliflozin and Linagliptin in Real World Indian Type 2 Diabetes Patient (GRID)
Rajiv Kovil, Banshi Saboo, Kiran Shah, et al.
Diabetes, Obesity & Metabolism
|
August 20, 2022
Insulin degludec/insulin aspart safely improves HbA1c: A long-term real-world cohort study (IDEA)
Jothydev Kesavadev, Banshi Saboo, Rajiv Kovil, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 27, 2023
Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
Viswanathan Mohan, Shashank Joshi, Ambrish Mithal, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 25, 2022
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting
Manoj Chadha, Ashok Kumar Das, Prasun Deb, et al.
The Journal of the Association of Physicians of India
|
October 14, 2016
Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India
Viswanathan Mohan, Sunil Jain, Jothydev Kesavadev, et al.
Scientific Reports
|
October 27, 2024
One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study
Paramesh Shamanna, Ravi Sankar Erukulapati, Ashutosh Shukla, et al.
Cureus
|
December 8, 2021
Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
Kamal Sharma, A B Chandorkar, Rajiv Kovil, et al.
The Journal of the Association of Physicians of India
|
September 9, 2022
Sodium-glucose Cotransporter-2 Inhibitors in Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus: A Meta-analysis
Rajiv Kovil, Manoj Chawla, Tejas Shah, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The Journal of the Association of Physicians of India
|
July 3, 2020
Study of Beneficial Impact on Specific Biomarkers in Type 2 Diabetes During Ramadan Fasting (Unintentional Intermittent Fasting)
Rajiv Kovil, Nida Shaikh
Indian Journal of Endocrinology and Metabolism
|
January 10, 2014
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Mumbai cohort of the A1chieve study
P G Talwalkar, Vishal Gupta, Rajiv Kovil
The Journal of the Association of Physicians of India
|
September 26, 2020
Single-pill Combination of Empagliflozin and Linagliptin in Real World Indian Type 2 Diabetes Patient (GRID)
Rajiv Kovil, Banshi Saboo, Kiran Shah, et al.
Diabetes, Obesity & Metabolism
|
August 20, 2022
Insulin degludec/insulin aspart safely improves HbA1c: A long-term real-world cohort study (IDEA)
Jothydev Kesavadev, Banshi Saboo, Rajiv Kovil, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 27, 2023
Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
Viswanathan Mohan, Shashank Joshi, Ambrish Mithal, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 25, 2022
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting
Manoj Chadha, Ashok Kumar Das, Prasun Deb, et al.
The Journal of the Association of Physicians of India
|
October 14, 2016
Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India
Viswanathan Mohan, Sunil Jain, Jothydev Kesavadev, et al.
Scientific Reports
|
October 27, 2024
One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study
Paramesh Shamanna, Ravi Sankar Erukulapati, Ashutosh Shukla, et al.
Cureus
|
December 8, 2021
Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
Kamal Sharma, A B Chandorkar, Rajiv Kovil, et al.
The Journal of the Association of Physicians of India
|
September 9, 2022
Sodium-glucose Cotransporter-2 Inhibitors in Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus: A Meta-analysis
Rajiv Kovil, Manoj Chawla, Tejas Shah, et al.
Page
of 2